Route of Infection in Melioidosis by Barnes, Jodie L. & Ketheesan, Natkunam
LETTERS
patients with SARS and upper respira-
tory symptoms might be coinfected
with other respiratory viruses and
become superspreaders. Interestingly,
the report on a SARS superspreading
event in Hong Kong explicitly states
that the superspreader had presented
with a “runny nose” (in addition to
fever, cough, and malaise) (3).
Therefore, upper respiratory symp-
toms might be a marker for highly
infectious SARS patients. Future
investigations, based upon either exist-
ing specimens from the last outbreak
or newly collected specimens from
any future outbreak, should focus on
whether an association exits between
SARS superspreading events and coin-
fection with other respiratory viruses.
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Route of Infection
in Melioidosis
To the Editor: Melioidosis is an
emerging tropical infectious disease,
the incidence of which is unknown in
many developing countries because of
the lack of diagnostic tests and med-
ical practitioners’lack of awareness of
the disease. It is a potentially fatal dis-
ease caused by the soil bacterium
Burkholderia pseudomallei. Clinical
manifestations, severity, and duration
of  B. pseudomallei infection vary
greatly (1).
Melioidosis develops after subcu-
taneous infection, inhalation, or
ingestion of contaminated particles or
aerosols. Infection has occurred after
near-drowning accidents (1–3) and
transmission of B. pseudomallei in
drinking water (4). The route of B.
pseudomallei infection is at least 1 of
the factors that influences disease out-
come, thus contributing to the broad
spectrum of clinical signs associated
with melioidosis. Researchers use dif-
ferent routes of delivery of B. pseudo-
mallei in experimental models to
study the pathogenesis of the disease
and the induction of host protection.
Infection by different routes exposes a
pathogen to different components of
the host immune system and may sub-
sequently influence disease outcome.
Despite this difference, no compre-
hensive investigation has compared
the pathogenesis of melioidosis estab-
lished by different routes of infection.
Following intravenous (IV) injec-
tion, BALB/c mice are highly suscep-
tible, and C57BL/6 mice are relative-
ly resistant to B. pseudomallei infec-
tion (5). Using this murine model, we
compared the pathogenesis of B.
pseudomallei infection after introduc-
ing the bacterium by IV, intraperi-
toneal (IP), intranasal, oral, and sub-
cutaneous (SC) routes of infection.
The virulence of 2 B. pseudomallei
strains (NCTC 13178 and NCTC
13179) was compared in BALB/c and
C57BL/6 mice by using a modified
version of the Reed & Meunch (1938)
method. Compared to BALB/c mice,
C57BL/6 mice are less susceptible to
B. pseudomallei infection, regardless
of the portal of entry, thus validating
the model of differential susceptibility
for various routes of infection (Table).
However, as demonstrated by others
(5–7), C57BL/6 mice are not com-
pletely resistant to infection by B.
pseudomallei. Systemic melioidosis
can be generated in C57BL/6 mice by
using different routes of infection, if a
high dose is used. When injected IV
into BALB/c mice, NCTC 13178 is
highly virulent since the 50% lethal
dose (LD50) is <10 CFU. However, if
BALB/c mice are injected SC with
NCTC 13178, the LD50 value increas-
es 100-fold to 1 x 103 CFU. This value
is equivalent to the LD50 of the less
virulent NCTC 13179 delivered SC
The results emphasize that virulence
depends on the route of infection.
The pathogenesis of B. pseudoma-
llei NCTC 13178 infection was com-
pared after infection by the IV, IP, SC,
intranasal, and oral routes. BALB/c
and C57BL/6 mice were administered
570 CFU (equivalent to 60 x LD50
delivered IV) or 3 x 105 CFU (equiv-
alent to 60 x LD50 delivered IV),
respectively. At 1, 2, and 3 days
postinfection, bacterial loads were
measured in blood, spleen, liver,
lungs, lymph nodes (right and left
axillary and inguinal), and brain by
using methods described previously
(5). 
A tropism for spleen and liver was
demonstrated following infection by
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each of the 5 routes. B. pseudomallei
could be detected in the tissues of IV-
and IP-infected mice earlier and in
higher numbers than in those of
intranasally and orally-infected mice,
despite the fact that all mice received
equal numbers of bacteria. This find-
ing reflects differences in the innate
immune response, depending on the
route of infection. Bacterial numbers
in mice infected by the IV or IP route
reached >106 CFU by day 2 postinfec-
tion, which indicates a failure of the
innate immune response to control
infection, leading to overwhelming
sepsis and death. 
Bacterial loads in tissues after
challenge with a lethal dose of highly
virulent NCTC 13178 did not indicate
any tropism for the lung after
intranasal infection. As early as day 1,
bacterial loads were greatest in the
liver and spleen, not lungs, of
C57BL/6 and BALB/c mice follow-
ing intranasal challenge. This finding
suggests a very early systemic spread
of B. pseudomallei from the lungs to
other organs. 
Bacteria were detected in the
brains of all mice after infection by
either the IV, IP, intranasal, or oral
route. Colonies recovered from the
brains of C57BL/6 mice infected by
the intranasal or oral routes were
mucoid in appearance. In comparison,
bacteria recovered from brains of
C57BL/6 mice that were challenged
by the IV or IProute demonstrated the
characteristic wrinkled shape on
Ashdown agar and may have been a
consequence of the overwhelming
septicemia that spilled over to all
organs. Variation in colonial morphol-
ogy of B. pseudomallei has been doc-
umented previously (8), and biofilm
formation may be an adaptation of B.
pseudomallei that enables it to evade
host immune responses or to survive
within unfavorable environments
(9,10). The variation in colonial mor-
phology on Ashdown agar observed
in bacteria isolated from brains of
C57BL/6 mice infected by the
intranasal or oral route may reflect a
change to biofilm formation of B.
pseudomallei in this tissue. 
In summary, the results of this
study reiterate the validity of the
mouse model for differential suscepti-
bility to B. pseudomallei, regardless of
the route of infection. The data also
emphasize that virulence depends on
the portal of entry of B. pseudomallei.
Researchers should, therefore, be par-
ticularly cautious when comparing
and extrapolating data from studies
that use different methods of infection. 
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Bordetella 
pertussis in Adult
Pneumonia
Patients
1
To the Editor: Although B. per-
tussis infection is well-characterized
in children, the epidemiology and
clinical spectrum of pertussis in ado-
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